The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation

Diabetologia

Volumn 41, Issue 5, 1998, Pages 584-588

  Suzuki, S ^a   Hinokio, Y ^a   Ohtomo, M ^a   Hirai, M ^a   Hirai, A ^a   Chiba, M ^a   Kasuga, S ^a   Satoh, Y ^a   Akai, H ^a   Toyota, T ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

C peptide; Deafness; Insulin; Lactate; Mitochondrial DNA mutation

Indexed keywords

ADENINE; C PEPTIDE; GLUCAGON; GLUCOSE; GUANINE; INSULIN; LACTIC ACID; MITOCHONDRIAL DNA; UBIDECARENONE; DRUG DERIVATIVE; UBIQUINONE;

ADULT; AMINO ACID SUBSTITUTION; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; EXERCISE; EXTRACHROMOSOMAL INHERITANCE; FEMALE; GENE MUTATION; HEARING ACUITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PERCEPTION DEAFNESS; PRIORITY JOURNAL; BLOOD; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FAMILY HEALTH; GENETICS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEARING; HEARING IMPAIRMENT; MIDDLE AGED; MOTHER; POINT MUTATION; TIME; TREATMENT OUTCOME; URINE;

ADULT; C-PEPTIDE; DEAFNESS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; DNA, MITOCHONDRIAL; FAMILY HEALTH; FEMALE; GLUCAGON; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEARING; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; MOTHERS; POINT MUTATION; TIME FACTORS; TREATMENT OUTCOME; UBIQUINONE;

EID: 0031596402     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050950     Document Type: Article

References (25)

1. Ballinger SW, Shoffner JM, Hedaya EV et al. (1992) Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nature Genetics 1: 11-15
2. LEU(uuR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genetics 1: 368-371
3. Kadowaki T, Kadowaki H, Mon Y et al. (1994) A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. New Engl J Med 330: 962-968
4. Maassen JA, Kadowaki T (1996) Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia 39: 375-382
5. 10 in Kearns-Sayre syndrome. Neurology 35: 372-377
6. 10 in Kearns-Sayre syndrome. Neurology 36: 45-53
7. 10. Neurology 36: 45-53
8. 10 administration. J Neurol Neurosurg Psychiatry 50: 1475-1481
9. Goda S. Hamada T, Ishimoto S et al. (1987) Clinical improvement after administration of coenzyme Q 10 in a patient with mitochondrial encephalomyopathy. J Neurol 234: 62-63
10. 31P NMR study. Neurology 39: 399-403
11. Zierz S, Jahns G, Jerusalem F (1989) Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus. J Neurol 236: 97-101
12. Bresolin N, Doriguzzi C, Ponzetto C et al. (1990) Ubide-carenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial. J Neurol Sci 100: 70-78
13. Abe K, Fujimura H, Nishikawa Y et al. (1991) Marked reduction in CSF Iactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy. lactic acidosis and stroke-like episodes (MELAS). Acta Neurol Scand 83: 356-359
14. 10 treatment in mitochondrial encephalomyopathy. Eur Neurol 37: 212-218
15. 10. Endocr J 42: 141-145
16. Leu(UUR) mutation; Case reports. Diabetes Res Clin Pract 29: 137-142
17. LEU(UUR) gene: A study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). Diabetologia 37: 818-825
18. American Diabetes Association. (1991) Official guide to diagnosis and classification of diabetes mellitus and other categories of glucose intolerance. Diabetes Care 14: 3-4
19. Leu(UUR) gene. Laryngoscope 106: 49-53
20. Takeda M, Ikenoya S, Yuzuriha T, Katayama K (1982) Studies on reduced and oxidized coenzyme Q in mitochondria. microsome and plasma by high-performance liquid chromatography. Biochem Biophys Acta 679: 308-314
21. 10 and L-carnitine be a treatment for diabetes secondary to 3243 mutation of mtDNA? Diabetologia 39: 1485-1486
22. Ogasahara S, Engel AG, Frens D et al. (1989) Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 86: 2379-2382
23. Frei B, Kim MC, Ames BN (1990) Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci USA 87: 4879-4883
24. Beyer RE, Segura-Aguilar J. Di Bernardo S et al. (1996) The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc Natl Acad Sci USA 93: 2528-2532
25. Richter C (1995) Oxidative damage to mitochondrial DNA and its relationship to aging. Int J Biochem Cell Biol 27: 647-653